GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritvic Regulatory News (BVIC)

Share Price Information for Britvic (BVIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 981.00
Bid: 971.50
Ask: 972.50
Change: 3.50 (0.36%)
Spread: 1.00 (0.103%)
Open: 985.50
High: 985.50
Low: 966.00
Prev. Close: 977.50
BVIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Three Bottling Facilities in France

1 Oct 2020 07:00

RNS Number : 7728A
Britvic plc
01 October 2020
 

Britvic plc

("Britvic" or the "Company")

Legal Entity Identifier: 635400L3NVMYD4BVCI53

 

1 October 2020

 

Britvic Sale of Three Bottling Facilities in France

 

Britvic is pleased to confirm that following approval by the French Competition Authority in July, Britvic has now completed the sale of its juice assets in France to Refresco. The sale includes the three juice manufacturing sites, related private label juice business and the Fruité brand.

Britvic retains ownership of the Pressade and Fruit Shoot brands, which will be manufactured by Refresco as part of a long-term partnership arrangement. The transaction will not affect the Teisseire and Moulin De Valdonne brands or the private label syrups business, all of which are all manufactured at the company's production site in Crolles.

This transaction supports our stated strategic priority to improve operating margins in our Western European markets, while also enables our teams to focus on growing our soft drinks portfolio of local favourite and global premium brands.

 

For further information please contact:

Investors:

Joanne Wilson (Chief Financial Officer) +44 (0) 7881 751550

Steve Nightingale (Director of Investor Relations) +44 (0) 7808 097784

Media:

Stephanie Macduff-Duncan (Head of Corporate Communications) +44 (0) 7808 097680

Stephen Malthouse (Headland) +44 (0) 7734 956201

 

Notes to editors

About Britvic

Britvic is one of the leading branded soft drinks businesses in Europe. The company combines its own leading brand portfolio including Fruit Shoot, Robinsons, Tango, J2O, London Essence, Teisseire and MiWadi with PepsiCo brands such as Pepsi, 7UP and Lipton Ice Tea which Britvic produces and sells in GB and Ireland under exclusive PepsiCo agreements.

Britvic is the largest supplier of branded still soft drinks in Great Britain ("GB") and the number two supplier of branded carbonated soft drinks in GB. Britvic is an industry leader in the island of Ireland with brands such as MiWadi and Ballygowan, in France with brands such as Teisseire, Pressade and Moulin de Valdonne and in Brazil with Maguary, Bela Ischia and Dafruta. Britvic is growing its reach into other territories through franchising, export and licensing. Britvic's management team has successfully developed the business through a clear strategy of organic growth and international expansion based on creating and building scale brands. Britvic is listed on the London Stock Exchange under the code BVIC and is a constituent of the FTSE250 index.

Cautionary note regarding forward-looking statements

This announcement includes statements that are forward-looking in nature. Forward-looking statements involve known and unknown risks, uncertainties and other factors including as a consequence of the Covid-19 pandemic, which may cause the actual results, performance or achievements of the group to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by the Listing Rules and applicable law, Britvic undertakes no obligation to update or change any forward-looking statements to reflect events occurring after the date such statements are published.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFIFFEIILLIII
Date   Source Headline
20th Aug 20183:49 pmRNSDirector/PDMR Shareholding
15th Aug 20181:17 pmRNSBlock listing Interim Review
15th Aug 20181:15 pmRNSBlock listing Interim Review
3rd Aug 20189:05 amRNSHolding(s) in Company
31st Jul 201811:32 amRNSTotal Voting Rights
24th Jul 20187:00 amRNSTrading Statement
23rd Jul 20184:11 pmRNSDirector/PDMR Shareholding
17th Jul 201811:10 amRNSDirector/PDMR Shareholding
29th Jun 201810:54 amRNSTotal Voting Rights
28th Jun 20181:17 pmRNSBlock listing Interim Review
26th Jun 201811:02 amRNSDirector/PDMR Shareholding
4th Jun 20181:31 pmRNSDirector/PDMR Shareholding
31st May 20189:31 amRNSTotal Voting Rights
29th May 20181:11 pmRNSDirector/PDMR Shareholding
23rd May 20187:00 amRNSHalf-year Report
10th May 201810:01 amRNSDirector Declaration
1st May 20181:26 pmRNSDirector/PDMR Shareholding
30th Apr 20185:08 pmRNSTotal Voting Rights
4th Apr 20185:38 pmRNSDirector/PDMR Shareholding
29th Mar 20183:03 pmRNSTotal Voting Rights
26th Mar 20182:54 pmRNSBlock listing Interim Review
5th Mar 20184:14 pmRNSDirector/PDMR Shareholding
5th Mar 20181:44 pmRNSHolding(s) in Company
28th Feb 20181:21 pmRNSTotal Voting Rights
15th Feb 20181:10 pmRNSBlock listing Interim Review
15th Feb 20181:07 pmRNSBlock listing Interim Review
15th Feb 201810:39 amRNSHolding(s) in Company
8th Feb 20182:21 pmRNSDirector/PDMR Shareholding
7th Feb 201811:02 amRNSDirector/PDMR Shareholding - Amendment
7th Feb 201811:02 amRNSDirector/PDMR Shareholding
7th Feb 201810:57 amRNSDirector/PDMR Shareholding - Amendment
7th Feb 201810:49 amRNSDirector/PDMR Shareholding - Amendment
7th Feb 201810:44 amRNSDirector/PDMR Shareholding
1st Feb 20189:03 amRNSResult of AGM - amendment
31st Jan 20182:12 pmRNSTotal Voting Rights
31st Jan 20181:09 pmRNSResult of AGM
31st Jan 20187:00 amRNSTrading Statement
24th Jan 20184:41 pmRNSDirector Declaration
12th Jan 201812:19 pmRNSDirector/PDMR Shareholding
12th Jan 201812:17 pmRNSDirector/PDMR Shareholding
2nd Jan 20187:00 amRNSTotal Voting Rights
28th Dec 20171:18 pmRNSBlock listing Interim Review
22nd Dec 201711:54 amRNSAnnual Financial Report
20th Dec 20174:27 pmRNSDirector/PDMR Shareholding
19th Dec 20174:28 pmRNSDirector/PDMR Shareholding
11th Dec 20175:14 pmRNSDirector/PDMR Shareholding
6th Dec 20175:43 pmRNSDirector/PDMR Shareholding
4th Dec 20174:57 pmRNSDirector/PDMR Shareholding
30th Nov 20174:52 pmRNSTotal Voting Rights
29th Nov 20177:30 amRNSDirectorate Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.